2014
DOI: 10.1021/jo501248e
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Neplanocin A and Its 3′-Epimer via an Intramolecular Baylis–Hillman Reaction

Abstract: The key cyclopentenyl intermediate 11b was synthesized in 4 steps from d-ribose in 41% overall yield via an efficient intramolecular Baylis-Hillman reaction. This novel key intermediate can be modified easily and transformed to neplanocin A (1a) and its 3'-epimer (1b).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
14
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 83 publications
(41 reference statements)
0
14
0
Order By: Relevance
“…was added to a solution of 21 (2.94 g, 6.28 mmol, 1.0 eq.) HRMS (ESI-TOF) m/z: [MþH] þ Calculated for C 34 Compound 23 (0.524 g, 1.33 mmol, 1.0 eq.) 2-methoxypropene (5.80 mL, 62.8 mmol, 10.0 eq.)…”
Section: Tert-butyl (2r3r4r)-2-((benzyloxy)methyl)-4-(((tertbutyldimentioning
confidence: 99%
“…was added to a solution of 21 (2.94 g, 6.28 mmol, 1.0 eq.) HRMS (ESI-TOF) m/z: [MþH] þ Calculated for C 34 Compound 23 (0.524 g, 1.33 mmol, 1.0 eq.) 2-methoxypropene (5.80 mL, 62.8 mmol, 10.0 eq.)…”
Section: Tert-butyl (2r3r4r)-2-((benzyloxy)methyl)-4-(((tertbutyldimentioning
confidence: 99%
“…Another analog of neplanocin, the (-)-3′-epi neplanocin A (22), was reported by Tan et al [8] through a reactional pathway conducive to the introduction of all desired stereocenters in one step ( Figure 4). The intermediate 20 was prepared in two steps, starting from the d -ribose in an overall yield of 60%.…”
Section: Synthesis Of the Carbocyclic Neplanocinsmentioning
confidence: 99%
“…Synthesis of 3′-epi neplanocin A.Data taken from[8] Synthesis of ara-neplanocin. Data taken from[10].…”
mentioning
confidence: 99%
“…[5] Due to strong biological activities as well as interesting structural features, (amino)cyclopentitols attract attention of both biologists and organic chemists as potential therapeutics for the treatment of carbohydrate-metabolism-related disorders. Carbocyclic nucleosides such as neplanocin A (5), [13] aristeromycin (6) [14] and their numerous analogues [15][16][17][18][19] exhibit antiviral, antibacterial and antitumor activity. Carbocyclic nucleosides such as neplanocin A (5), [13] aristeromycin (6) [14] and their numerous analogues [15][16][17][18][19] exhibit antiviral, antibacterial and antitumor activity.…”
Section: Introductionmentioning
confidence: 99%